Edwards Lifesciences Corporation is a global structural heart innovation company. Co. is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. We show 64 historical shares outstanding datapoints in our EW shares outstanding history coverage, used to compute EW market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing EW market cap history over the course of time is important for investors
interested in comparing EW's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of EW versus a peer is one thing; comparing
EW market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like EW can fluctuate over the course of history.
With this page we aim to empower investors researching EW by allowing them to research the EW market cap history. |
Free EW Email Alerts:
Video: The Importance of Market Cap
